By Steve Usdin
Contributing Editor

WASHINGTON - The results of months of hyperactive, but largely stealthy, efforts by numerous parties to influence congressional action on FDA reform will be thrown into the open the next two weeks as the Senate and House of Representatives finish crafting legislation and begin to debate it in public.